TRIM38 has been shown to be capable of activating NF-κB signaling pathways (31) and may participate in regulating innate immune response, various pathophysiological processes, such as bone proliferation, tumorigenesis, and autoimmune diseases (10, 13). Here, NFKB1 is linked to autoimmune disease.